Home 2017-12-21T13:31:38+00:00

Product Finder

Product Finder

GMP Quality

With over 20 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space.

CellGenix was the first company to obtain a GMP manufacturing authorization for therapeutic cell processing in Europe. Being an ATMP manufacturer ourselves allowed us to gain in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements you face during product development and the regulatory approval process. We can help simplify your raw material qualificatition and validation efforts by offering expert technical and regulatory support. 

 

We are able to guarentee a consistent high product quality as all relevant GMP guidelines are followed for each step from initial development to final Quality Control (QC) release after manufacturing.

Our GMP raw materials offer a maximum of quality and safety due to state-of-the-art production, stringent quality control and comprehensive documentation.

Read more

 

Safe │ GMP Compliant │ Reliable 

 

 

GMP Quality

With over 20 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space.

Our GMP grade raw materials offer a maximum of quality and safety due to state-of-the-art production, stringent quality control and comprehensive documentation.

Read more 

News

  • Jan 2018

    New Preclinical Cytokine

    We proudly announce the launch of CAP® cell line derived recombinant human Transforming Growth Factor-beta 1. This product contains neither animal- nor human-derived materials ensuring maximum safety for optimal use in preclinical cell and gene therapy applications.

    Read more

  • Oct 2017

    CellGenix Lecture - Prof. Luc Douay

    We are excited to announce the 4th CellGenix Lecture given by Prof. Luc Douay from Paris, France. The title of his lecture will be "In vitro red blood cell generation: from bench to factory".

    Read more

  • Sep 2017

    Article - Cell & Gene Therapy Europe

    The cell and gene therapy space has seen a great deal of growth and progress over the last couple of years as more companies are approaching late-stage clinical development and market authorization.But what does this mean for the manufacturing process? What challenges remain and how can they be overcome?

    Read more

Events

Jan 2018
23/01 - 25/01

Phacilitate Cell & Gene Therapy World

Miami, FL | USA
 
30/01 - 31/01

Combined CAR-T Congress Europe

Berlin | Germany

Where are you located?

Note: You have to select a country.